[Molecular biology in genetic counseling of Duchenne and Becker myopathy].
From 1985-1991, molecular biology studies were carried out in 115 families affected with X-linked muscular dystrophy (DMD/BMD), including 59 prenatal diagnoses. The approach has changed over the last 6 years when new intragenic markers and cDNA probes became available. The polymerase chain reaction technique allows a rapid detection of dystrophin deletions, but classical Southern blot technique remains useful for restriction length polymorphism analysis. Fifty percent (42/85) of patients with DMD/BMD exhibited deletions of the dystrophin gene. In affected families with a detectable deletion, carrier detection is possible by gene dosage analysis and prenatal diagnosis is reliable. When no deletion is found, carrier detection and prenatal diagnosis depends on linkage analysis using polymorphic probes. Due to the high recombination rate, several markers need to be used. The information provided by linkage analysis must be interpreted given the proper family structure.
Philip
N
N
Centre de génétique médicale et Inserm U242, hôpital d'enfants de La Timone, Marseille, France.
Voelckel
M A
MA
Girardot
L
L
Lambert
J C
JC
Moncla
A
A
Mattei
J F
JF
Giraud
F
F
D005260:Female; D017353:Gene Deletion; D005817:Genetic Counseling; D006801:Humans; D008297:Male; D008403:Mass Screening; D008967:Molecular Biology; D009136:Muscular Dystrophies / Q000235:genetics* / Q000378:metabolism / Q000517:prevention & control; D011247:Pregnancy; D011296:Prenatal Diagnosis
La biologie moléculaire dans le conseil génétique des myopathies de Duchenne et de Becker.